Psychedelic-Assisted Psychotherapy for Addiction: Techniques, Indications and Clinical Outcomes

Psychedelic-Assisted Psychotherapy for Addiction: Techniques, Indications and Clinical Outcomes

Gabriel Thorens, Louise Penzenstadler, Daniel ZullinoLecture Hall 121 (ESA West)

This workshop aims to explore the use of psychedelic-assisted psychotherapy (PAP) in treating patients with addiction, focusing on substances like LSD and psilocybin. As addiction continues to challenge traditional therapeutic methods, emerging research highlights the promising role of psychedelics in treating substance use disorders. The workshop will provide participants with a comprehensive understanding of how these substances are utilized in a psychotherapeutic in Geneva University Hospital.

Participants will be introduced to the key psychotherapeutic skills required when working with patients undergoing psychedelic-assisted treatment. This includes understanding the set and setting, establishing trust, and navigating the emotional and psychological responses that arise during sessions. Specific psychotherapeutic interventions will be discussed, emphasizing the importance of integration sessions post-experience to ensure lasting therapeutic effects.

Additionally, the workshop will cover the clinical indications and contraindications for using psychedelics in addiction treatment. Discussion will include patient screening processes, assessing readiness for treatment, and managing potential risks associated with psychedelic substances, including psychological distress or adverse reactions. Participants will learn about the careful balance required to maximize therapeutic benefits while minimizing harm.

Preliminary data on the success rates of psychedelic-assisted psychotherapy for addiction in Geneva Universit Hospital will be presented, along with insights from clinical trials and case studies. These examples will illustrate the potential benefits, challenges, and outcomes of treatment, offering a realistic perspective on the integration of psychedelics in clinical practice.

By the end of the session, attendees will have a deeper understanding of how psychedelic-assisted psychotherapy can be effectively used as a tool in addiction treatment.

Thorens G, Penzenstadler L, Seragnoli F, Rothen S, Qusaj V, Zullino D. Ethics in the practice of psychedelic-assisted psychotherapy]. Rev Med Suisse. 2023 Aug 23;19(838):1508-1512. French. doi: 10.53738/REVMED.2023.19.838.1508. PMID: 37610195. Seragnoli F, Thorens G, Penzenstadler LE, De Carvalho Furtado LC, Buchard A, Bachmann S, Iuga R, Khatcherian E, Nowotarski A, Sabe M, Richard Lepouriel H, Glangetas A, Girani L, Anastasova RB, Girardet AS, Yang R, Lécureux L, Alaux S, Mabilais C, Amberger Repond CM, Dubuc C, Szczesniak L, Blanc J, Tudor M, Elrhaoussi A, de Chambrier PP, Petignat C, Rochat L, Briefer J-F, Rothen S, Aboulafia Brakha T, Qusaj V, Cheminal S, Billieux J, Zullino DF. Psychothérapie assistée par psychédéliques (PAP) : le modèle genevois. Ann Med Psychol 2024;182(9)806-813. Seragnoli F, Pires Martins D, Thorens G. Microdosing LSD: practices and risks. Rev Med Suisse. 2021 Jun 9;17(742):1108-1110.
Tue 16:45 - 18:15
Workshop
Scroll to Top